Terrance P. Coyne, EVP & CFO at Royalty Pharma plc (RPRX), sold 64,399 shares at $53.98 ($3.5M) on 2026-05-26, disclosed to the SEC on 2026-05-28.
Scheduled sale ($3.5M) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RPRX | SELL | 2026-04-02 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-03-25 | $3.2M | — | Filing → |
| RPRX | SELL | 2026-03-04 | $3.3M | — | Filing → |